114 related articles for article (PubMed ID: 21701532)
1. Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
Bossow S; Grossardt C; Temme A; Leber MF; Sawall S; Rieber EP; Cattaneo R; von Kalle C; Ungerechts G
Cancer Gene Ther; 2011 Aug; 18(8):598-608. PubMed ID: 21701532
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment.
Dempe S; Lavie M; Struyf S; Bhat R; Verbeke H; Paschek S; Berghmans N; Geibig R; Rommelaere J; Van Damme J; Dinsart C
Cancer Immunol Immunother; 2012 Nov; 61(11):2113-23. PubMed ID: 22576056
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.
Grossardt C; Engeland CE; Bossow S; Halama N; Zaoui K; Leber MF; Springfeld C; Jaeger D; von Kalle C; Ungerechts G
Hum Gene Ther; 2013 Jul; 24(7):644-54. PubMed ID: 23642239
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic viral therapy for pancreatic cancer.
Rahal A; Musher B
J Surg Oncol; 2017 Jul; 116(1):94-103. PubMed ID: 28407327
[TBL] [Abstract][Full Text] [Related]
5. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy.
Gujar S; Pol JG; Kumar V; Lizarralde-Guerrero M; Konda P; Kroemer G; Bell JC
Nat Protoc; 2024 May; ():. PubMed ID: 38769145
[TBL] [Abstract][Full Text] [Related]
6. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.
Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q
BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691
[TBL] [Abstract][Full Text] [Related]
7. Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer.
Luo W; Wang Y; Zhang T
Cancer Cell Int; 2022 Apr; 22(1):160. PubMed ID: 35443724
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic virus therapy in cancer: A current review.
Santos Apolonio J; Lima de Souza Gonçalves V; Cordeiro Santos ML; Silva Luz M; Silva Souza JV; Rocha Pinheiro SL; de Souza WR; Sande Loureiro M; de Melo FF
World J Virol; 2021 Sep; 10(5):229-255. PubMed ID: 34631474
[TBL] [Abstract][Full Text] [Related]
9. Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions.
Lu SY; Hua J; Xu J; Wei MY; Liang C; Meng QC; Liu J; Zhang B; Wang W; Yu XJ; Shi S
Int J Biol Sci; 2021; 17(10):2666-2682. PubMed ID: 34326701
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer.
Singh HM; Leber MF; Bossow S; Engeland CE; Dessila J; Grossardt C; Zaoui K; Bell JC; Jäger D; von Kalle C; Ungerechts G
Mol Ther Oncolytics; 2021 Jun; 21():340-355. PubMed ID: 34141871
[TBL] [Abstract][Full Text] [Related]
11. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.
Holbrook MC; Goad DW; Grdzelishvili VZ
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803211
[TBL] [Abstract][Full Text] [Related]
12. Measles Virus as an Oncolytic Immunotherapy.
Engeland CE; Ungerechts G
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535479
[TBL] [Abstract][Full Text] [Related]
13. Engineering and combining oncolytic measles virus for cancer therapy.
Leber MF; Neault S; Jirovec E; Barkley R; Said A; Bell JC; Ungerechts G
Cytokine Growth Factor Rev; 2020 Dec; 56():39-48. PubMed ID: 32718830
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic virotherapy in hepato-bilio-pancreatic cancer: The key to breaking the log jam?
Li Y; Shen Y; Zhao R; Samudio I; Jia W; Bai X; Liang T
Cancer Med; 2020 May; 9(9):2943-2959. PubMed ID: 32130786
[TBL] [Abstract][Full Text] [Related]
15. Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus.
May V; Berchtold S; Berger A; Venturelli S; Burkard M; Leischner C; Malek NP; Lauer UM
Oncol Lett; 2019 Nov; 18(5):5534-5542. PubMed ID: 31612061
[TBL] [Abstract][Full Text] [Related]
16. Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells.
Tai CJ; Liu CH; Pan YC; Wong SH; Tai CJ; Richardson CD; Lin LT
Sci Rep; 2019 May; 9(1):6767. PubMed ID: 31043633
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral generation of 2-fluoroadenine to treat solid malignancies of the head and neck.
Behbahani TE; Rosenthal EL; Parker WB; Sorscher EJ
Head Neck; 2019 Jun; 41(6):1979-1983. PubMed ID: 30633420
[TBL] [Abstract][Full Text] [Related]
18. The Role of Oncolytic Viruses in the Treatment of Melanoma.
Bayan CY; Lopez AT; Gartrell RD; Komatsubara KM; Bogardus M; Rao N; Chen C; Hart TD; Enzler T; Rizk EM; Pradhan JS; Marks DK; Geskin LJ; Saenger YM
Curr Oncol Rep; 2018 Aug; 20(10):80. PubMed ID: 30145781
[TBL] [Abstract][Full Text] [Related]
19. Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.
Parker WB; Sorscher EJ
Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29119917
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
